STATE STREET CORP - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 257 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$81,633,455
-10.5%
2,137,561
-3.6%
0.01%0.0%
Q2 2023$91,210,094
-26.7%
2,217,605
+2.3%
0.01%
-28.6%
Q1 2023$124,406,551
-47.3%
2,166,984
-48.5%
0.01%0.0%
Q4 2022$235,935,384
+172.7%
4,207,872
+106.0%
0.01%
+40.0%
Q3 2022$86,526,000
-18.9%
2,042,640
+3.4%
0.01%
-16.7%
Q2 2022$106,715,000
-17.2%
1,975,106
-1.5%
0.01%0.0%
Q1 2022$128,849,000
-1.8%
2,005,127
+2.3%
0.01%0.0%
Q4 2021$131,239,000
-0.5%
1,959,089
+1.7%
0.01%
-14.3%
Q3 2021$131,875,000
+1.6%
1,925,748
+1.3%
0.01%0.0%
Q2 2021$129,785,000
+7.9%
1,901,884
+9.2%
0.01%0.0%
Q1 2021$120,321,000
+5.9%
1,741,509
-0.5%
0.01%0.0%
Q4 2020$113,659,000
+35.7%
1,750,757
-1.3%
0.01%
+16.7%
Q3 2020$83,777,000
-1.8%
1,774,190
-2.3%
0.01%0.0%
Q2 2020$85,307,000
+5.5%
1,815,419
+0.3%
0.01%
-14.3%
Q1 2020$80,824,000
-23.5%
1,809,347
-0.1%
0.01%0.0%
Q4 2019$105,599,000
-4.4%
1,811,929
-1.5%
0.01%
-12.5%
Q3 2019$110,487,000
-5.0%
1,839,311
-11.7%
0.01%
-11.1%
Q2 2019$116,292,000
+1.1%
2,082,225
+0.9%
0.01%0.0%
Q1 2019$115,013,000
+27.4%
2,064,120
+3.2%
0.01%
+12.5%
Q4 2018$90,246,000
-37.5%
2,001,012
-8.7%
0.01%
-27.3%
Q3 2018$144,378,000
+9.9%
2,191,848
+7.5%
0.01%0.0%
Q2 2018$131,334,000
+41.9%
2,038,991
+21.9%
0.01%
+37.5%
Q1 2018$92,574,000
-0.7%
1,672,808
-14.2%
0.01%0.0%
Q4 2017$93,272,000
+16.6%
1,948,982
+23.0%
0.01%
+14.3%
Q3 2017$79,998,000
-6.8%
1,584,846
+0.6%
0.01%
-12.5%
Q2 2017$85,860,000
+36.1%
1,575,125
+5.2%
0.01%
+33.3%
Q1 2017$63,070,000
+6.3%
1,497,043
+116.5%
0.01%0.0%
Q4 2016$59,334,000
+10.4%
691,617
+6.2%
0.01%
+20.0%
Q3 2016$53,745,000
+12.1%
651,072
+8.3%
0.01%0.0%
Q2 2016$47,962,000
+24.0%
601,205
+4.7%
0.01%
+25.0%
Q1 2016$38,676,000
+2.2%
574,172
+2.9%
0.00%0.0%
Q4 2015$37,838,000
+17.3%
558,192
+3.1%
0.00%0.0%
Q3 2015$32,253,000
-3.0%
541,637
+9.7%
0.00%0.0%
Q2 2015$33,263,000
+11.4%
493,742
+1.9%
0.00%
+33.3%
Q1 2015$29,861,000
+18.2%
484,356
+3.9%
0.00%0.0%
Q4 2014$25,273,000
+12.0%
465,997
+2.5%
0.00%
+50.0%
Q3 2014$22,569,000
+5.2%
454,693
-0.2%
0.00%0.0%
Q2 2014$21,447,000
-0.3%
455,767
-2.6%
0.00%0.0%
Q1 2014$21,512,000
-40.2%
467,837
-43.5%
0.00%0.0%
Q4 2013$35,976,000
+114.4%
827,907
+98.5%
0.00%0.0%
Q3 2013$16,780,000
+11.2%
417,067
+1.2%
0.00%0.0%
Q2 2013$15,088,000411,9280.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q3 2023
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders